May 19, 2026
RA Jainee
WhiteOak Capital Pharma and Healthcare Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 15.62 |
| NAV Bonus (Rs.) | — |
| NAV IDCW (Rs.) | — |
| Min. Investment (Rs.) | 500 |
| Min. SIP Investment (Rs.) | 100 |
| Min. No of Cheques | 6 |
| Benchmark | BSE Healthcare TRI |
| AUM Rs. | 603 Cr |
| (As on 30-Apr-2026) | |
| Expense | 0.86% |
| 1 Year Return (%) | 18.59 |
| 3 Year Return (%) | — |
| 5 Year Return (%) | — |
| 10 Year Return (%) | — |
| Return Since Launch | 21.70% |
⚖️ Sahifund Review – WhiteOak Capital Pharma and Healthcare Fund ✔
PLUS: Stability, track record, cost efficiency
X
MINUS: Large AUM, large-cap bias, momentum lag
X
Sahifund View (Decisive Line):
X
👉 Apply Online | Ask Us MF Queries |
| NFO Guidance |
What lies ahead? Below we decode returns consistency, portfolio concentration, peer positioning and risk profile in detail.
Suitable For Which Investors?
Nobody should invest in Pharma funds in our opinion, because:
• They have a narrow focus on only pharmaceutical and healthcare companies
• Instead, diversified equity funds which invest across sectors are better
If you still choose to invest:
1. Invest only through SIP
2. Have a 7+ year investment horizon
3. Be prepared to withstand interim sharp declines in investment value
Fund’s Investment Strategy:
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund Manager:
1) Ramesh Mantri
Education: Mr. Mantri is an MBA, CFA and CA
Experience: Prior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.
2) Trupti Agrawal
Education: Ms. Agrawal has done B.Com and CA.
Experience: Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.
3) Piyush Baranwal
Education: Mr.Piyush Baranwal is a B. Tech. in Electronics and communication from Manipal Institute of Technology,Manipal.He completed PGDBM in Finance from S.P.Jain Institute of Management and Reserch and CFA.
Experience: Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
4) Dheeresh Pathak
Education: Mr. Pathak has done B.E in Electronics Engineering and a PGDBM from MDI Gurgaon
Experience: Prior to joining WhiteOak Capital Mutual Fund, he has worked with Goldman Sachs
5) Ashish Agrawal
Education: PGDBM in Finance from Institute of Management Technology, Ghaziabad and Bachelor of Commerce from University of Lucknow
Experience: Prior to joining Whiteoak Capital AMC, he was working with Motilal Owal Asset Management Co. Ltd from 2016 till date. Citigroup Global Markets Ltd from 2010 to 2016
Investment Details
| Min. Investment (Rs) | 500 |
| Min. Addl Investment (Rs) | 500 |
| Min. SIP Investment (Rs) | 100 |
| Min. Withdrawal (Rs) | 500 |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 0 |
Basic Details of WhiteOak Capital Pharma and Healthcare Fund
| Fund House | WhiteOak Capital Mutual Fund |
| Launch Date | 06-Feb-24 |
| Return Since Launch | 21.70% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | 603 Cr |
| (As on 30-Apr-2026) | |
| Expense | 0.86% |
| (As on 30-Apr-2026) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 200.00% |
WhiteOak Capital Pharma and Healthcare Fund Returns
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| WhiteOak Capital Pharma and Healthcare Dir | 10.01 | 0.13 | 8.88 | 11.08 | 6.85 | 18.59 | — | — | — | — |
| BSE Healthcare TRI | 7.92 | 0.18 | 9.16 | 10.76 | 5.87 | 11.48 | — | — | — | — |
| Equity: Sectoral-Pharma | 8.17 | 0.05 | 8.44 | 10.43 | 6.14 | 13.11 | — | — | — | — |
| Rank within category | 5 | 13 | 12 | 8 | 9 | 2 | — | — | — | — |
| Number of funds in category | 24 | 25 | 25 | 24 | 23 | 21 | 12 | 10 | 8 | 4 |
Peer Comparison of WhiteOak Capital Pharma and Healthcare Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| WhiteOak Capital Pharma and Healthcare Dir | Unrated | 18.59 | — | — | 0.86 | 603 | 21.70 | — | 2Y 3M | 200.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 5 out of 5 stars | 11.26 | 29.56 | 17.44 | 1.62 | 6,669 | 21.29 | 1.00 (15) | 7Y 10M | 57.00 |
| SBI Healthcare Opportunities Dir | 5 out of 5 stars | 11.43 | 27.38 | 17.13 | 0.92 | 4,323 | 17.71 | 0.50 (15) | 13Y 4M | 25.00 |
| UTI Healthcare Dir | 4 out of 5 stars | 13.29 | 28.01 | 15.46 | 1.36 | 1,144 | 16.01 | 1.00 (30) | 13Y 4M | 33.00 |
| Nippon India Pharma Dir | 3 out of 5 stars | 10.69 | 25.19 | 14.76 | 1.48 | 8,365 | 17.61 | 1.00 (30) | 13Y 4M | 14.00 |
WhiteOak Capital Pharma and Healthcare Fund Portfolio
| No. of Stocks | 53 |
| Top 10 Stocks | 46.57% |
| Top 5 Stocks | 29.37% |
| Top 3 Sectors | 99.17% |
| Portfolio P/B Ratio | 6.73 |
| Portfolio P/E Ratio | 45.14 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 45,785 | 77,752 |
| Giant (%) | — | — |
| Large (%) | 23.58 | 41.80 |
| Mid (%) | 25.06 | 31.80 |
| Small (%) | 51.36 | 28.94 |
| Tiny (%) | — | — |
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status